celecoxib has been researched along with Cancer of Rectum in 7 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "With a lower efficacy than Sou-Medrol in decreasing postoperative inflammation, celecoxib produces a better effect in inhibiting COX-2 expression, but it does not lower postoperative recurrence rate of rectal cancer." | 5.20 | [Perioperative immunomodulatory therapy does not decrease postoperative recurrence rate of rectal cancer]. ( Gan, ZM; Li, L; Liu, D; Lv, DH; Wang, XD, 2015) |
| "Patients with clinical stage II or III rectal cancer were treated with radiotherapy of 44 Gy in 22 fractions." | 2.79 | Celecoxib plus chemoradiotherapy for locally advanced rectal cancer: a phase II TCOG study. ( Chen, HC; Chen, HH; Chen, WT; Chien, CR; Hsiao, CF; Lee, HH; Lin, TC; Lin, TY; Liu, TW; Wang, LW, 2014) |
| "Celecoxib dosage was fixed." | 2.75 | A phase I study of capecitabine, irinotecan, celecoxib, and radiation as neoadjuvant therapy of patients with locally advanced rectal cancer. ( Alqaisi, M; Bernal, P; Bush, D; Byrd, J; Garberoglio, C; Hussein, F; Malik, I, 2010) |
| "Some rectal cancers respond well to preoperative neoadjuvant therapy while others are inherently resistant or develop resistance during the treatment." | 2.72 | Molecular responses of rectal cancer to preoperative chemoradiation. ( Debucquoy, A; Geboes, K; Goethals, L; Haustermans, K; Mc Bride, WH; Roels, S, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, LW | 1 |
| Hsiao, CF | 1 |
| Chen, WT | 1 |
| Lee, HH | 1 |
| Lin, TC | 1 |
| Chen, HC | 1 |
| Chen, HH | 1 |
| Chien, CR | 1 |
| Lin, TY | 1 |
| Liu, TW | 1 |
| Gan, ZM | 1 |
| Wang, XD | 1 |
| Lv, DH | 1 |
| Liu, D | 1 |
| Li, L | 1 |
| Debucquoy, A | 2 |
| Roels, S | 2 |
| Goethals, L | 2 |
| Libbrecht, L | 1 |
| Van Cutsem, E | 1 |
| Geboes, K | 2 |
| Penninckx, F | 1 |
| D'Hoore, A | 1 |
| McBride, WH | 1 |
| Haustermans, K | 2 |
| Malik, I | 1 |
| Hussein, F | 1 |
| Bush, D | 1 |
| Alqaisi, M | 1 |
| Bernal, P | 1 |
| Byrd, J | 1 |
| Garberoglio, C | 1 |
| Unger, KR | 1 |
| Romney, DA | 1 |
| Koc, M | 1 |
| Moskaluk, CA | 1 |
| Friel, CM | 1 |
| Foley, EF | 1 |
| Rich, TA | 1 |
| Mc Bride, WH | 1 |
| Jakobsen, A | 1 |
| Mortensen, JP | 1 |
| Bisgaard, C | 1 |
| Lindebjerg, J | 1 |
| Rafaelsen, SR | 1 |
| Bendtsen, VO | 1 |
6 trials available for celecoxib and Cancer of Rectum
| Article | Year |
|---|---|
Celecoxib plus chemoradiotherapy for locally advanced rectal cancer: a phase II TCOG study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Celecoxib; Chemoradioth | 2014 |
[Perioperative immunomodulatory therapy does not decrease postoperative recurrence rate of rectal cancer].
Topics: C-Reactive Protein; Celecoxib; Cyclooxygenase 2 Inhibitors; Humans; Immunomodulation; Inflammation; | 2015 |
Double blind randomized phase II study with radiation+5-fluorouracil+/-celecoxib for resectable rectal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Celecoxib; Combined Modality Therapy; D | 2009 |
A phase I study of capecitabine, irinotecan, celecoxib, and radiation as neoadjuvant therapy of patients with locally advanced rectal cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitab | 2010 |
Molecular responses of rectal cancer to preoperative chemoradiation.
Topics: Adult; Aged; Biomarkers, Tumor; Celecoxib; Cyclooxygenase 2; Female; Fluorouracil; Humans; Immunohis | 2006 |
A COX-2 inhibitor combined with chemoradiation of locally advanced rectal cancer: a phase II trial.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cardiovascular | 2008 |
1 other study available for celecoxib and Cancer of Rectum
| Article | Year |
|---|---|
Preoperative chemoradiation for rectal cancer using capecitabine and celecoxib correlated with posttreatment assessment of thymidylate synthase and thymidine phosphorylase expression.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cape | 2011 |